Key facts
- This page summarizes Jennifer Streeter's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Jun 2023, 16:47.
Jennifer Streeter - 12 Jun 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)
- Reporting relationship
- COO & VP of HR
- Issuer ticker
- CATX
- Reported as of
- 12 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2023, 16:47:21 UTC
- Prior SEC filing
- 22 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Streeter
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jennifer Streeter filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 14 Jun 2023.
Change
- Previous filing in this sequence was filed on 22 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CATX
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- +41%
- Price
- $0.000000
- Shares after
- 1,722,500
- Date
- 12 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500,000
- Exercise price
- $0.5500
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested.